These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11190602)

  • 1. Nonparametric tests for stratum effects in the Cox model.
    Sun J; Yang I
    Lifetime Data Anal; 2000 Dec; 6(4):321-30. PubMed ID: 11190602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A smooth test in proportional hazard survival models using local partial likelihood fitting.
    Kauermann G; Berger U
    Lifetime Data Anal; 2003 Dec; 9(4):373-93. PubMed ID: 15000411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of covariate imbalance on the size of the logrank test in randomized clinical trials.
    Kinukawa N; Nakamura T; Akazawa K; Nose Y
    Stat Med; 2000 Aug; 19(15):1955-67. PubMed ID: 10900445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of covariate effects in Aalen's additive hazard model.
    Lee E; Weissfeld LA
    Stat Med; 1998 May; 17(9):983-98. PubMed ID: 9612886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of time-to-event data using a flexible mixture model under a constraint of proportional hazards.
    Liu GF; Liao JJZ
    J Biopharm Stat; 2020 Sep; 30(5):783-796. PubMed ID: 32589509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance.
    Saville BR; Koch GG
    J Biopharm Stat; 2013 Mar; 23(2):477-90. PubMed ID: 23437952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical likelihood for cumulative hazard ratio estimation with covariate adjustment.
    Dong B; Matthews DE
    Biometrics; 2012 Jun; 68(2):408-18. PubMed ID: 22059527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for treatment-biomarker interaction based on local partial-likelihood.
    Liu Y; Jiang W; Chen BE
    Stat Med; 2015 Nov; 34(27):3516-30. PubMed ID: 26084729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials.
    Horiguchi M; Cronin AM; Takeuchi M; Uno H
    Stat Med; 2018 Jul; 37(15):2307-2320. PubMed ID: 29682762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonparametric covariate adjustment in estimating hazard ratios.
    Jiang H; Kulkarni PM; Wang Y; Mallinckrodt CH
    Pharm Stat; 2016; 15(1):46-53. PubMed ID: 26610282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample size.
    Xu R; Mehrotra DV; Shaw PA
    Pharm Stat; 2019 May; 18(3):366-376. PubMed ID: 30706642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric randomization-based covariate adjustment for stratified analysis of time-to-event or dichotomous outcomes.
    Hussey MA; Koch GG; Preisser JS; Saville BR
    J Biopharm Stat; 2016; 26(3):579-89. PubMed ID: 26101805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approximate nonparametric corrected-score method for joint modeling of survival and longitudinal data measured with error.
    Tapsoba JD; Lee SM; Wang CY
    Biom J; 2011 Jul; 53(4):557-77. PubMed ID: 21717494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for crossover of two hazard functions using Gail and Simon's method.
    Chen YH; Liu GH
    J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trials.
    Mehrotra DV; Marceau West R
    Stat Med; 2020 Dec; 39(30):4724-4744. PubMed ID: 32954531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.